The authors suggested that reduced acidosis following VD3 treatment may have downregulated the expression of the CYP24A1 gene, which encodes for an enzyme responsible for the catalytic degradation of VD3 to prevent its cell modulation in these glioma cells. Here, CYP24A1 is linked to glioma.